Target intelligence / Profile preview

Dietary macromolecules in gastrointestinal lumen and intestinal glycocalyx

Molecular classification
Other (Physiological compartment/Substrate group), Carbohydrate, Lipid, Protein, Mucin
01

Overview

The dietary macromolecules in the gastrointestinal lumen and the intestinal glycocalyx constitute the primary interface for nutrient processing and absorption in the human body. This complex environment includes ingested proteins, lipids, and carbohydrates, as well as the glycocalyx—a dense, carbohydrate-rich layer of glycoproteins and glycolipids on the apical surface of intestinal epithelial cells (Source: NIH/NCBI - PMC4951383). The glycocalyx acts as a physical barrier and a scaffold for essential brush border enzymes, such as sucrase-isomaltase and peptidases, which facilitate the final stages of digestion before transport into the bloodstream (Source: StatPearls - NBK544242). Pathological alterations in this environment are linked to conditions like malabsorption, obesity, and inflammatory bowel disease. Therapeutic strategies often involve modulating the activity of enzymes within this space, such as using alpha-glucosidase inhibitors like acarbose for diabetes or lipase inhibitors like orlistat for weight management (Source: PubChem - Compound 444290, 3034034). Additionally, luminal binders like sevelamer are used to sequester ions such as phosphate directly within the gastrointestinal tract to manage systemic metabolic imbalances.

Other names
Gut lumen contentsIntestinal brush border glycocalyxEnteric mucus layerLuminal nutrientsIntestinal surface coat
02

Mechanism of action

Inhibition of luminal enzymes (e.g., lipases, alpha-glucosidases), physical sequestration of nutrients or ions, osmotic modulation of luminal fluid, and enzymatic replacement of deficient digestive factors.

03

Biological functions

DigestionAbsorptionBarrier functionMetabolismMicrobiome niche maintenance
04

Disease associations

ObesityDiabetes mellitusMalabsorption syndromeInflammatory bowel diseaseHyperphosphatemiaCeliac disease
05

Safety considerations

SteatorrheaFlatulenceAbdominal crampingMalabsorption of fat-soluble vitamins (A, D, E, K)Diarrhea
06

Interacting drugs

Acarbose

6 more in the full profile.

07

Biomarkers

Fecal fat contentHydrogen breath testD-xylose absorption testIntestinal permeability (Lactulose/Mannitol ratio)Fecal elastase

Beyond the preview

Go deeper on Dietary macromolecules in gastrointestinal lumen and intestinal glycocalyx.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary macromolecules in gastrointestinal lumen and intestinal glycocalyx.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call